5G wireless technology has the potential to revolutionize clinical trials and research in healthcare by enabling faster and more reliable data transmission and communication between devices. Here are some ways in which this technology can impact clinical trials and research: Remote Monitoring With 5G, it becomes easier to monitor patients remotely and collect data in […]
Clinical trials are an essential component of drug development and medical research. The results of clinical trials help determine the safety and efficacy of new drugs and medical devices. The clinical laboratory is an integral part of clinical trials as it is responsible for generating reliable and accurate data that is critical to the success
10 Tenets of Good Clinical Laboratory Practices in Clinical Trials Read More »
Digital clinical trials (DCTs), a recently emerging paradigm since the onset of COVID-19 address many of the inefficiencies of traditional trials, however, to implement and scale this approach, developers will need to accommodate shifts in operational models and embrace new technology. On the other hand, Traditional clinical research is necessary for developing new medical technologies,
Critical stakeholders in the trials ecosystem mainly sponsors and regulators want to see more than just test results and metrics when reviewing treatments. Criteria such as delayed disease progression and absence of side effects are impressive measures; however, they do not give a clear overview of the patient’s experience. Only a patient understands the impact
Impacting Treatment Experience – Through the Optics of the Patient Read More »
Clinical trials are an integral part of medical research and play a critical role in advancing healthcare. They provide a way to test new treatments and medicines, determine their safety and effectiveness, and improve patient care. For people in Africa, participating in clinical trials can have numerous benefits, both for individual health and for the
Clinical Trials in Africa: Exploring the 5 Benefits of Participating in Medical Research Read More »
The lack of diversity in Clinical Trial participants has some significant negative effects on both the African population and the Clinical Trial sponsors. Sponsors pass up the chance to carry out very inexpensive research with a broad patient group, frequently enrolling people who have never had any therapy for their ailment while the populace has
Diversity in Clinical Trials and Research: 9 Reasons Why It Matters Read More »
A paradigm shift for increased diversity in clinical trials cannot be overemphasized post-covid-19 pandemic. Identifying, recruiting, and retaining study participants are critical to trial success. However, in cases of participants who are ethnically diverse, the challenges are particularly profound. The persistent overrepresentation of white participants in clinical trials is particularly striking as consideration is not
Driving Equity in Clinical Trials with a Diversity First Mindset…….Meeting The Need. Read More »
In the last decade, there has been a gradual increase in the acceptance of decentralized clinical trials (DCTs), one trend that has accelerated dramatically due to the pandemic. Now, there will be no going back, primarily due to the convenience and flexibility for patients. By minimizing the burden of participating in a clinical trial, sponsors
Decentralized Clinical Trials; More than Industry Buzzword Read More »
There’s no shortage of digital solutions in today’s innovation-fueled clinical research space at every stage of the clinical trial journey. Still, there’s a lot of room for improvement, especially when it comes to the patient experience. Consider the rapid increase of patient and site-facing technologies – from digital patient outreach to eConsent, sensors and wearables, telehealth,
Improving the Patient Experience in Clinical Trials Read More »
Work has experienced a major transformation and this shift and the changes it precipitated have affected how we now conduct and perform monitoring of clinical trials. Years ago, it would be had been an abnormality in the clinical trial industry to propose any notion of conducting clinical trial procedures or trial monitoring activities in any
Monitoring of Clinical Trials …Adapting to the Paradigm Shift Read More »
